|
Mediphase Capital Partners is a life sciences-focused
hedge fund seeking capital appreciation primarily in small cap life sciences
companies. The fund is characterized by the use of risk management strategies to
achieve an optimal risk/reward profile. The fund staff includes 4 investment
professionals, all of whom have extensive operating experience in life sciences
companies as well as investment experience.
Fund strategy: Long and short investments
|
